benzene and nitrosamines)
Zheng L, Abhyankar W, Ouwerling N, Dekker HL, van Veen H, Vander Wel NN, Roseboom W, de Koning LJ, Brul S, de Koster CG
Consolidate overlapping mechanisms and focus on mechanistic diversity: one copper peptide, one tissue repair peptide, one metabolic or GH-axis compound
To advance translational applications, future studies should focus on: (1) transforming dynamic biomarkers into clinical decision-making tools, such as evaluating early changes in circulating mitochondrial-derived vesicles or oxidative stress markers (e.g., 8isoprostaglandin F2 (8-iso-PGF2))to predict subsequent biochemical and histological responses
Outcome after detection of minimal residual disease during treatment with the modified hyper-CVAD regimen with or without rituximab in newly diagnosed adult acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LL)
Myth-Busting: GLP-1 Supplements, Drops, and Over-the-Counter Claims FDA and medical experts warn that over-the-counter GLP-1 boosters, pills, or drops are not true medications